Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis
PMID: 38863178
Source: Clin Pharmacol Ther
Publication date:
2025-07-24
Year:
2024
Abstract
NULL